Bovie Medical PE Ratio 2006-2019 | APYX

Current and historical p/e ratio for Bovie Medical (APYX) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bovie Medical PE ratio as of July 19, 2019 is 0.00.
Bovie Medical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-07-22 6.65 3.89
2019-03-31 6.31 $1.71 3.69
2018-12-31 6.48 $1.82 3.56
2018-09-30 7.10 $1.91 3.72
2018-06-30 4.35 $-0.11 0.00
2018-03-31 2.97 $-0.14 0.00
2017-12-31 2.60 $-0.17 0.00
2017-09-30 3.38 $-0.18 0.00
2017-06-30 2.47 $-0.18 0.00
2017-03-31 2.67 $-0.16 0.00
2016-12-31 3.59 $-0.17 0.00
2016-09-30 5.21 $-0.18 0.00
2016-06-30 1.64 $-0.20 0.00
2016-03-31 1.67 $-0.24 0.00
2015-12-31 2.10 $0.40 5.25
2015-09-30 1.95 $0.06 32.50
2015-06-30 2.79 $-0.05 0.00
2015-03-31 2.39 $-0.06 0.00
2014-12-31 3.68 $-1.18 0.00
2014-09-30 3.99 $-0.93 0.00
2014-06-30 3.63 $-0.78 0.00
2014-03-31 3.90 $-0.77 0.00
2013-12-31 2.15 $-0.24 0.00
2013-09-30 2.82 $-0.08 0.00
2013-06-30 2.95 $-0.06 0.00
2013-03-31 3.30 $0.01 0.00
2012-12-31 2.42 $0.04 60.50
2012-09-30 3.60 $-0.03 0.00
2012-06-30 2.39 $-0.03 0.00
2012-03-31 2.70 $-0.02 0.00
2011-12-31 2.12 0 0.00
2011-09-30 2.92 $-0.03 0.00
2011-06-30 2.61 $-0.03 0.00
2011-03-31 3.10 $-0.05 0.00
2010-12-31 3.28 $-0.09 0.00
2010-09-30 2.16 $-0.01 0.00
2010-06-30 2.98 $-0.01 0.00
2010-03-31 6.25 0 0.00
2009-12-31 7.81 $0.03 260.33
2009-09-30 7.85 $0.03 261.67
2009-06-30 8.71 $0.05 174.20
2009-03-31 6.60 $0.12 55.00
2008-12-31 6.24 $0.11 56.73
2008-09-30 6.84 $0.13 52.63
2008-06-30 7.15 $0.14 51.07
2008-03-31 6.40 $0.12 53.33
2007-12-31 6.40 $0.14 45.71
2007-09-30 7.00 $0.14 49.98
2007-06-30 6.02 $0.16 37.63
2007-03-31 7.10 $0.14 50.71
2006-12-31 9.07 $0.15 60.47
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.214B $0.017B
Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.83
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.27
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.544B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.03
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
LeMaitre Vascular (LMAT) United States $0.598B 28.97
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
Capricor Therapeutics (CAPR) United States $0.020B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00